The Milngavie Apothecary's Company Limited

POWER SEARCH PRICING

SOLUTIONS

the milngavie apothecary's company limited Company Information

Live

MatureSmallHealthy

Company Number

SC251342

Website

Registered Address

100 high street, linlithgow, west lothian, EH49 7AQ

Industry

Dispensing chemist in specialised stores

Telephone

Next Accounts Due

June 2025

Group Structure

View All

Directors

Kenneth Wilson20 Years

Scott Wilson10 Years

View All

Shareholders

kenneth john wilson 50%

susan elaine wilson 50%

the milngavie apothecary's company limited Estimated Valuation

£0 - £13.3m

The estimated valuation range for the milngavie apothecary's company limited, derived from financial data as of September 2023 and the most recent industry multiples, is between £0 to £13.3m

Get a detailed valuation report, edit figures and unlock valuation multiples.

The Milngavie Apothecary's Company Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

The Milngavie Apothecary's Company Limited is a live company located in west lothian, EH49 7AQ with a Companies House number of SC251342. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in June 2003, it's largest shareholder is kenneth john wilson with a 50% stake. The Milngavie Apothecary's Company Limited is a mature, small sized company, Pomanda has estimated its turnover at £4.1m with healthy growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded The Milngavie Apothecary'S Company Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating4out of 5

3 Strong

4 Regular

5 Weak

Size

annual sales of £4.1m, make it smaller than the average company (£12.4m)

Growth

3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (5.8%)

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for the milngavie apothecary's company limited. Get real-time insights into the milngavie apothecary's company limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for the milngavie apothecary's company limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

THE MILNGAVIE APOTHECARY'S COMPANY LIMITED group structure

The Milngavie Apothecary'S Company Limited has no subsidiary companies.

Ultimate parent company

THE MILNGAVIE APOTHECARY'S COMPANY LIMITED

SC251342

THE MILNGAVIE APOTHECARY'S COMPANY LIMITED Shareholders

kenneth john wilson	50%
susan elaine wilson	50%

The Milngavie Apothecary'S Company Limited currently has 5 directors. The longest serving directors include Mr Kenneth Wilson (Aug 2003) and Mr Scott Wilson (Feb 2014).

officer	country	age	start	end	role
Mr Kenneth Wilson		64 years	Aug 2003	-	Director
Mr Scott Wilson		30 years	Feb 2014	-	Director
Mr Colin Wilson		35 years	Feb 2014	-	Director
Mr Graeme Wilson		36 years	Feb 2014	-	Director
Mr Steven Wilson	Scotland	33 years	Feb 2014	-	Director

EXPORT

The Milngavie Apothecary'S Company Limited's latest turnover from September 2023 is estimated at £4.1 million and the company has net assets of £5.7 million. According to their latest financial statements, The Milngavie Apothecary'S Company Limited has 40 employees and maintains cash reserves of £911.2 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Turnover	4,073,684	4,317,685	3,662,942	3,360,601	2,858,597	2,974,577	2,971,269	2,616,451	3,423,210	3,356,174	3,857,788	2,768,931	2,696,988	7,458,886	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	2,823,580	2,909,589	2,510,944	2,356,363	2,029,352	2,065,763	2,042,131	1,777,562	2,399,509	2,334,403	2,650,614	1,944,515	1,901,961	5,211,944	0
Gross Profit	1,250,104	1,408,096	1,151,998	1,004,238	829,244	908,813	929,138	838,889	1,023,702	1,021,771	1,207,175	824,416	795,027	2,246,942	0
Admin Expenses	1,624,912	2,010,673	838,444	953,079	968,374	640,132	479,875	355,355	881,755	701,096	902,754	481,888	574,735	1,867,152	-1,582,091
Operating Profit	-374,808	-602,577	313,554	51,159	-139,130	268,681	449,263	483,534	141,947	320,675	304,421	342,528	220,292	379,790	1,582,091
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	39,299	13,966	1,377	2,510	23,172	28,168	9,842	8,762	15,504	13,369	11,375	9,113	4,539	2,319	1,674
Pre-Tax Profit	-335,509	-588,611	314,931	53,669	-115,958	296,849	459,105	492,296	157,451	334,044	315,796	351,641	224,831	382,108	1,583,765
Tax	0	0	-59,837	-10,197	0	-56,401	-87,230	-98,459	-31,490	-70,149	-72,633	-84,394	-58,456	-106,990	-443,454
Profit After Tax	-335,509	-588,611	255,094	43,472	-115,958	240,448	371,875	393,837	125,961	263,895	243,163	267,247	166,375	275,118	1,140,311
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-335,509	-588,611	255,094	43,472	-115,958	240,448	371,875	393,837	125,961	263,895	243,163	267,247	166,375	275,118	1,140,311
Employee Costs	910,845	821,303	606,518	617,453	575,393	572,616	555,486	404,959	518,051	504,825	555,132	370,753	358,393	958,852	0
Number Of Employees	40	38	30	32	31	31	31	23	30	29	33	22	21	57	0
EBITDA*	-48,754	-279,191	636,428	318,890	128,577	524,742	700,114	720,267	415,800	607,640	584,709	627,238	497,572	655,681	1,863,475

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Tangible Assets	312,907	324,630	430,518	268,380	295,250	300,751	319,940	315,132	308,506	389,557	208,267	282,626	354,625	425,055	501,717
Intangible Assets	237,318	419,055	600,789	782,522	964,256	1,145,990	1,327,724	1,509,457	1,691,191	1,872,925	2,054,658	2,236,392	2,418,126	2,599,860	2,781,594
Investments & Other	2,891,309	2,948,309	2,940,407	1,234,907	894,302	727,569	272,260	202,260	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	52,327	43,311	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	3,441,534	3,744,321	4,015,025	2,285,809	2,153,808	2,174,310	1,919,924	2,026,849	1,999,697	2,262,482	2,262,925	2,519,018	2,772,751	3,024,915	3,283,311
Stock & work in progress	360,723	331,958	343,375	343,579	307,583	317,463	317,446	326,145	370,072	363,102	328,380	342,313	333,438	353,016	327,897
Trade Debtors	350,064	468,826	430,770	416,952	347,316	358,224	399,270	356,115	428,517	414,740	615,967	381,072	394,005	1,465,973	377,345
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	246,056	141,212	303,322	284,431	200,104	763,160	54,601	78,210	5,391	9,998	0	0	0	0	1,178
Cash	911,229	660,740	580,711	2,172,709	2,847,762	3,331,363	4,180,090	3,693,388	3,316,519	2,885,006	2,462,582	2,087,528	1,557,662	257,874	669,604
misc current assets	1,274,071	1,545,552	1,895,093	2,168,402	0	236,878	0	0	0	0	0	0	0	0	0
total current assets	3,142,143	3,148,288	3,553,271	5,386,073	4,902,956	5,007,088	4,951,407	4,453,858	4,120,499	3,672,846	3,406,929	2,810,913	2,285,105	2,076,863	1,376,024
total assets	6,583,677	6,892,609	7,568,296	7,671,882	7,056,764	7,181,398	6,871,331	6,480,707	6,120,196	5,935,328	5,669,854	5,329,931	5,057,856	5,101,778	4,659,335
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	730,921	713,781	655,067	630,056	599,686	487,209	475,663	444,210	618,945	543,361	564,712	466,009	453,984	666,657	494,023
Group/Directors Accounts	874	0	0	0	0	0	2,767	2,380	0	4,226	4,226	4,174	3,829	260	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	105,163	96,600	127,924	607,726	72,174	191,066	130,267	137,923	0	0	0	0	0	0	0
total current liabilities	836,958	810,381	782,991	1,237,782	671,860	678,275	608,697	584,513	618,945	547,587	568,938	470,183	457,813	666,917	494,023
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	114,466	18,355	12,631	14,892	14,851	20,286	19,180	31,631	8,701	10,696	18,238	19,431	25,000
total long term liabilities	0	0	114,466	18,355	12,631	14,892	14,851	20,286	19,180	31,631	8,701	10,696	18,238	19,431	25,000
total liabilities	836,958	810,381	897,457	1,256,137	684,491	693,167	623,548	604,799	638,125	579,218	577,639	480,879	476,051	686,348	519,023
net assets	5,746,719	6,082,228	6,670,839	6,415,745	6,372,273	6,488,231	6,247,783	5,875,908	5,482,071	5,356,110	5,092,215	4,849,052	4,581,805	4,415,430	4,140,312
total shareholders funds	5,746,719	6,082,228	6,670,839	6,415,745	6,372,273	6,488,231	6,247,783	5,875,908	5,482,071	5,356,110	5,092,215	4,849,052	4,581,805	4,415,430	4,140,312

	Sep 2023	Sep 2022	Sep 2021	Sep 2020	Sep 2019	Sep 2018	Sep 2017	Sep 2016	Sep 2015	Sep 2014	Sep 2013	Sep 2012	Sep 2011	Sep 2010	Sep 2009
Operating Activities
Operating Profit	-374,808	-602,577	313,554	51,159	-139,130	268,681	449,263	483,534	141,947	320,675	304,421	342,528	220,292	379,790	1,582,091
Depreciation	144,317	141,652	141,141	85,997	85,973	74,327	69,118	54,999	92,119	105,232	98,554	102,976	95,546	94,157	99,650
Amortisation	181,737	181,734	181,733	181,734	181,734	181,734	181,733	181,734	181,734	181,733	181,734	181,734	181,734	181,734	181,734
Tax	0	0	-59,837	-10,197	0	-56,401	-87,230	-98,459	-31,490	-70,149	-72,633	-84,394	-58,456	-106,990	-443,454
Stock	28,765	-11,417	-204	35,996	-9,880	17	-8,699	-43,927	6,970	34,722	-13,933	8,875	-19,578	25,119	327,897
Debtors	-66,245	-115,038	76,020	153,963	-573,964	667,513	19,546	417	9,170	-191,229	234,895	-12,933	-1,071,968	1,087,450	378,523
Creditors	17,140	58,714	25,011	30,370	112,477	11,546	31,453	-174,735	75,584	-21,351	98,703	12,025	-212,673	172,634	494,023
Accruals and Deferred Income	8,563	-31,324	-479,802	535,552	-118,892	60,799	-7,656	137,923	0	0	0	0	0	0	0
Deferred Taxes & Provisions	0	-114,466	96,111	5,724	-2,261	41	-5,435	1,106	-12,451	22,930	-1,995	-7,542	-1,193	-5,569	25,000
Cash flow from operations	14,429	-239,812	142,095	690,380	703,745	-126,803	620,399	629,612	431,303	695,577	387,822	551,385	1,316,796	-396,813	1,232,624
Investing Activities
capital expenditure	-132,594	-35,764	-303,279	-59,127	-80,472	-55,138	-73,926	-61,625	-11,068	-286,522	-24,195	-30,977	-25,116	-17,495	-3,564,695
Change in Investments	-57,000	7,902	1,705,500	340,605	166,733	455,309	70,000	202,260	0	0	0	0	0	0	0
cash flow from investments	-75,594	-43,666	-2,008,779	-399,732	-247,205	-510,447	-143,926	-263,885	-11,068	-286,522	-24,195	-30,977	-25,116	-17,495	-3,564,695
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	874	0	0	0	0	-2,767	387	2,380	-4,226	0	52	345	3,569	260	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3,000,001
interest	39,299	13,966	1,377	2,510	23,172	28,168	9,842	8,762	15,504	13,369	11,375	9,113	4,539	2,319	1,674
cash flow from financing	40,173	13,966	1,377	2,510	23,172	25,401	10,229	11,142	11,278	13,369	11,427	9,458	8,108	2,579	3,001,675
cash and cash equivalents
cash	250,489	80,029	-1,591,998	-675,053	-483,601	-848,727	486,702	376,869	431,513	422,424	375,054	529,866	1,299,788	-411,730	669,604
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	250,489	80,029	-1,591,998	-675,053	-483,601	-848,727	486,702	376,869	431,513	422,424	375,054	529,866	1,299,788	-411,730	669,604

P&L

September 2023

turnover

4.1m

-6%

operating profit

-374.8k

gross margin

30.7%

-5.9%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

September 2023

net assets

5.7m

-0.06%

total assets

6.6m

-0.04%

cash

911.2k

+0.38%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

abbey chemists ltd

4.5

deans pharmaceuticals ltd

james mckeever limited

3.5

ra guy limited

cmam pharmacy limited

company number

SC251342

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

June 2003

age

accounts

Total Exemption Full

ultimate parent company

None

previous names

lancaster shelf 64 limited (August 2003)

incorporated

address

100 high street, linlithgow, west lothian, EH49 7AQ

last accounts submitted

September 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to the milngavie apothecary's company limited.

the milngavie apothecary's company limited Company Information

the milngavie apothecary's company limited Estimated Valuation

the milngavie apothecary's company limited Estimated Valuation

the milngavie apothecary's company limited Estimated Valuation

The Milngavie Apothecary's Company Limited AI Business Plan

The Milngavie Apothecary's Company Limited Overview

The Milngavie Apothecary's Company Limited Health Check

the milngavie apothecary's company limited Credit Report and Business Information

The Milngavie Apothecary's Company Limited Competitor Analysis

the milngavie apothecary's company limited Ownership

the milngavie apothecary's company limited directors

THE MILNGAVIE APOTHECARY'S COMPANY LIMITED financials

the milngavie apothecary's company limited company details

the milngavie apothecary's company limited Charges & Mortgages

the milngavie apothecary's company limited Companies House Filings - See Documents